One batch each of olaparib 25 and 200 mg film-coated tablets have been placed on stability, using a bracketed design (in accordance with ICH Q1D ‘Bracketing and matrixing designs for stability testing of new drug substances and new drug products’), under long-term, accelerated and stressed conditions for up to 60 months.